Two more senior industry leaders are confirmed to speak at this year's BioPharmaDispatch conference with early-bird registration available until the end of February.
This year's conference will take place in Sydney on Monday 17 May. It is timed for the week after the federal government delivers the 2021-22 Budget.
It will be a hybrid in-person and virtual event, following the success of that format last year. Early-bird registration is available until the end of February.
AstraZeneca country president Liz Chatwin, who is also the deputy chair of Medicines Australia, will be joined by GSK vice president and country manager Christi Kelsey.
They will join a range of already and yet-to-be-confirmed speakers.
Those already confirmed include GBMA chair Jane Halton AO PSM, PBAC chair Professor Andrew Wilson, Janssen's chair for the Asia Pacific region Chris Hourigan, Pfizer's Anne Harris, Neil MacGregor of Bristol Myers Squibb, Liz de Somer of Medicines Australia, Dr Rachel David from Private Healthcare Australia and the MTAA's Ian Burgess.
Other confirmed speakers include Nexus chair and CEO Nick Campbell, Jody Fassina of Insight Strategy, the former chair of Medicines Australia Will Delaat AM and ex-deputy secretary of the Department of Health David Learmonth.
More speakers will be confirmed in the weeks ahead under an emerging theme of 'system stewardship'.
Last year's event emphasised patient participation and the 2021 conference will for the first time involve a stand-alone focus on patients.
It is hoped this builds on last year's event where patient group participation revealed what might be described as a gap between the 'insider' discussion and that involving the people the system is meant to serve. Patients and representatives of patient groups can access complimentary registration to the event (email@example.com).